VistaGen Therapeutics, Inc. - VTGN
About Gravity Analytica
Recent News
- 06.17.2025 - Vistagen Therapeutics Fiscal Year 2025 Fourth Quarter Corporate Update Conference Call
- 06.17.2025 - Vistagen Therapeutics Fiscal Year 2025 Fourth Quarter Corporate Update Conference Call
- 06.12.2025 - Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
- 06.12.2025 - Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
- 06.05.2025 - Jefferies Global Healthcare Conference
- 06.05.2025 - Jefferies Global Healthcare Conference
- 06.02.2025 - Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
- 06.02.2025 - Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
- 05.28.2025 - Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
- 05.28.2025 - Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York